Literature DB >> 12467749

Genotype-phenotype correlations in X-linked myotubular myopathy.

Meriel McEntagart1, Gretchen Parsons, Anna Buj-Bello, Valérie Biancalana, Iain Fenton, Mark Little, Michael Krawczak, Nick Thomas, Gail Herman, Angus Clarke, Carina Wallgren-Pettersson.   

Abstract

X-linked myotubular myopathy is a severe congenital myopathy that presents in the neonatal period with profound hypotonia and an inability to establish spontaneous respiration. Usually death occurs in infancy from respiratory failure. However, there is phenotypic variability; a number of affected boys have achieved respiratory independence and become ambulatory. Disease-causing mutations have been identified throughout the MTM1 gene on Xq28. MTM1 encodes the protein myotubularin, which is expressed ubiquitously. The main objectives of this study were to establish whether the nature or site of the mutation in the MTM1 gene could predict severity of the disease and to investigate whether early intensive clinical intervention facilitated survival until spontaneous improvement occurred. An association was demonstrated between the presence of a non-truncating mutation of the MTM1 gene and the mild phenotype. However, many non-truncating mutations were also seen in association with the severe phenotype and these were not confined to recognized functional domains of the protein. This suggests that the use of mutation analysis to predict prognosis in the early period following diagnosis is limited. Unexpectedly, over 50 patients surviving for more than 1 year were identified in this study. Further information obtained on 40 of these cases revealed that 50% were receiving 24-h ventilatory support, while 27% were ventilated at night only. The high survival rate for this disorder therefore reflects intensive medical intervention without which the majority of these boys would not survive.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12467749     DOI: 10.1016/s0960-8966(02)00153-0

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  49 in total

1.  Gene replacement rescues severe muscle pathology and prolongs survival in myotubularin-deficient mice and dogs.

Authors:  Martin K Childers; Alan H Beggs; Ana Buj-Bello
Journal:  Ann Transl Med       Date:  2015-10

2.  Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype.

Authors:  Christopher R Pierson; Ashley N Dulin-Smith; Ashley N Durban; Morgan L Marshall; Jordan T Marshall; Andrew D Snyder; Nada Naiyer; Jordan T Gladman; Dawn S Chandler; Michael W Lawlor; Anna Buj-Bello; James J Dowling; Alan H Beggs
Journal:  Hum Mol Genet       Date:  2011-11-07       Impact factor: 6.150

3.  Intravenous Administration of a MTMR2-Encoding AAV Vector Ameliorates the Phenotype of Myotubular Myopathy in Mice.

Authors:  Nathalie Danièle; Christelle Moal; Laura Julien; Martina Marinello; Thibaud Jamet; Samia Martin; Alban Vignaud; Michael W Lawlor; Ana Buj-Bello
Journal:  J Neuropathol Exp Neurol       Date:  2018-04-01       Impact factor: 3.685

4.  Type of PKD1 mutation influences renal outcome in ADPKD.

Authors:  Emilie Cornec-Le Gall; Marie-Pierre Audrézet; Jian-Min Chen; Maryvonne Hourmant; Marie-Pascale Morin; Régine Perrichot; Christophe Charasse; Bassem Whebe; Eric Renaudineau; Philippe Jousset; Marie-Paule Guillodo; Anne Grall-Jezequel; Philippe Saliou; Claude Férec; Yannick Le Meur
Journal:  J Am Soc Nephrol       Date:  2013-02-21       Impact factor: 10.121

5.  Phenotypic severity scoring system and categorisation for prune belly syndrome: application to a pilot cohort of 50 living patients.

Authors:  Daniel G Wong; Michelle K Arevalo; Niccolo Maria Passoni; Nida S Iqbal; Thomas Jascur; Adam J Kern; Emma J Sanchez; Arthi Satyanarayan; Jyothsna Gattineni; Linda A Baker
Journal:  BJU Int       Date:  2018-09-19       Impact factor: 5.588

6.  Characterization and genetic diagnosis of centronuclear myopathies in seven Chinese patients.

Authors:  Yan Zhao; Zhe Zhao; Hongrui Shen; Qi Bing; Jing Hu
Journal:  Neurol Sci       Date:  2018-09-19       Impact factor: 3.307

7.  X-linked myotubular myopathy in a family with two infant siblings: a case with MTM1 mutation.

Authors:  Ji Hyun Jeon; Ran Namgung; Min Soo Park; Kook In Park; Chul Lee; Jin Sung Lee; Se Hoon Kim
Journal:  Yonsei Med J       Date:  2011-05       Impact factor: 2.759

8.  Consensus statement on standard of care for congenital myopathies.

Authors:  Ching H Wang; James J Dowling; Kathryn North; Mary K Schroth; Thomas Sejersen; Frederic Shapiro; Jonathan Bellini; Hali Weiss; Marc Guillet; Kimberly Amburgey; Susan Apkon; Enrico Bertini; Carsten Bonnemann; Nigel Clarke; Anne M Connolly; Brigitte Estournet-Mathiaud; Dominic Fitzgerald; Julaine M Florence; Richard Gee; Juliana Gurgel-Giannetti; Allan M Glanzman; Brittany Hofmeister; Heinz Jungbluth; Anastassios C Koumbourlis; Nigel G Laing; Marion Main; Leslie A Morrison; Craig Munns; Kristy Rose; Pamela M Schuler; Caroline Sewry; Kari Storhaug; Mariz Vainzof; Nanci Yuan
Journal:  J Child Neurol       Date:  2012-03       Impact factor: 1.987

Review 9.  Congenital myopathies.

Authors:  Claudio Bruno; Carlo Minetti
Journal:  Curr Neurol Neurosci Rep       Date:  2004-01       Impact factor: 5.081

10.  Adult MTM1-related myopathy carriers: Classification based on deep phenotyping.

Authors:  Benjamin T Cocanougher; Lauren Flynn; Pomi Yun; Minal Jain; Melissa Waite; Ruhi Vasavada; Jason D Wittenbach; Sabine de Chastonay; Sameer Chhibber; A Micheil Innes; Linda MacLaren; Tahseen Mozaffar; Andrew E Arai; Sandra Donkervoort; Carsten G Bönnemann; A Reghan Foley
Journal:  Neurology       Date:  2019-09-20       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.